An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
Recruiting now
Conditions studied: Chronic Kidney Disease (CKD)
In brief
The main purpose of this study is to continue to see how vonsetamig works in the body and to monitor the outcomes after kidney transplant for participants previously treated in the R5459-RT-1944 study (NCT05092347). No study drug will be given during this study.
Key facts
- Study ID
- NCT05106387
- Run by
- Regeneron Pharmaceuticals
- People needed
- 20
- Starts
- 2023-10-19
- Expected to finish
- 2028-02-23
- Last updated by the study team
- 2026-07-20
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Received at least 1 dose of treatment with vonsetamig in study R5459-RT-1944 [NCT05092347].
- Received after acceptable crossmatching, a kidney transplant while enrolled in study R5459-RT-1944
- Willing and able to comply with clinic visits and study-related procedures
- Provide informed consent signed by study patient or legally acceptable representative
You may not qualify if…
- There are no exclusion criteria for this study.
- Note: Other protocol defined Inclusion/Exclusion criteria may apply
Where it is running
- Penn Transplant Institute — Philadelphia, Pennsylvania, United States (enrolling)
- University of California Irvine — Orange, California, United States (enrolling)
- Connie Frank Transplant Center at UCSF — San Francisco, California, United States (enrolling)
- University of Minnesota — Minneapolis, Minnesota, United States (enrolling)
- Cedars-Sinai Medical Center — Los Angeles, California, United States (enrolling)
- Comprehensive Transplant Center — Chicago, Illinois, United States (enrolling)
- John Hopkins Hospital — Baltimore, Maryland, United States (enrolling)
- Yale University of Medicine — New Haven, Connecticut, United States
- New York University Langone Health — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.